• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC OVERSTITCH¿ ENDOSCOPIC SUTURING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC OVERSTITCH¿ ENDOSCOPIC SUTURING SYSTEM Back to Search Results
Device Problem Migration (4003)
Patient Problems Abdominal Pain (1685); Diarrhea (1811); Perforation (2001); Vomiting (2144)
Event Date 06/12/2022
Event Type  malfunction  
Event Description
The reported events were found during a literature review.It was report several patient had the following symptoms - (4 patients) nausea, vomiting, abdominal pain, sore throats, diarrhea and (1 patient) esophageal perforation.The 4 patients were treated conservatively.One patient with the esophageal perforation was treated with a laparoscopic drainage without clinical evidence for perforation.All patients are doing well.
 
Manufacturer Narrative
Combined medwatch submitted to the fda on 27/jun/2023.A review of the device labeling notes the following: the current overstitch¿ endoscopic suturing system (ess) instructions for use (ifu) addressed the known and potential event of "esophageal perforation, nausea, vomiting, pain (abdominal), and other (sore throat) as follows: the apollo endosurgery overstitch¿ endoscopic suture system (ess) is intended for endoscopic placement of suture(s) and approximation of soft tissue.Possible complications that may result from using the endoscopic suturing system include, but may not be limited to: pharyngitis / sore throat, nausea and / or vomiting, abdominal pain and / or bloating, hemorrhage, hematoma, conversion to laparoscopic or open procedure, stricture, infection / sepsis, pharyngeal, colonic and/or esophageal perforation, esophageal, colonic and/or pharyngeal laceration, intra-abdominal (hollow or solid) visceral injury, aspiration, wound dehiscence, acute inflammatory tissue reaction, death.Note: any serious incident that has occurred in relation to the device should be reported to apollo endosurgery and any appropriate government entity.Additional information: the device has not been returned for analysis and attempts to gather more information from the reporter is not visible as this is a literature review, and the author does not have the information for the device.The investigator determined a device history record (dhr) review is not possible.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVERSTITCH¿ ENDOSCOPIC SUTURING SYSTEM
Type of Device
ENDOSCOPIC SUTURING SYSTEM
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC
1120 s. captail of texas hwy
bldg 1, ste 300
austin 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA, SRL
coyol free zone
building b 13.3
alajuela, cs CRI
CS   CRI
Manufacturer Contact
adriana russell
1120 s. captail of texas hwy
bldg 1, ste 300
austin 78746
5122795114
MDR Report Key17210952
MDR Text Key317950893
Report Number3006722112-2023-00134
Device Sequence Number1
Product Code OCW
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K081853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-